<DOC>
	<DOCNO>NCT00611039</DOCNO>
	<brief_summary>Basing study relate darunavir ( DRV ) virtual inhibitory quotient ( vIQ ) virological response , possible think possibility simplify rescue treatment DRV/ritonavir 900/100 mg day patient treat DRV/ritonavir 600/100 mg twice day , besides undetectable viral load , vIQ 2 . This strategy would jeopardize efficacy antiretroviral treatment would less impact lipid profile patient well less pharmaceutical expenditure .</brief_summary>
	<brief_title>Evaluate Efficacy Security Darunavir/Ritonavir 900/100 mg Once Day Antiretroviral Treatment Simplification Strategy</brief_title>
	<detailed_description>The probability achieve viral replication suppression treatment DRV relate extent viral resistance DRV ( inhibitory concentration 50 % , IC50 ) drug concentration . Moreover , DRV virtual inhibitory quotient ( vIQ ) relate significantly virological response DRV treatment . So patient DRV vIQ &gt; = 1,5 8-times high probability viral load &lt; 50 copies/mL 24 week treatment vIQ &lt; 1,5 . Considering previous argument , possible think possibility simplify rescue treatment DRV/ritonavir 900/100 mg day patient treat DRV/ritonavir 600/100 mg twice day , besides undetectable viral load , DRV vIQ 2 . This strategy would jeopardize efficacy antiretroviral treatment would less impact lipid profile patient well less pharmaceutical expenditure .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<criteria>1 . Age &gt; = 18 year . 2 . HIVinfected patient . 3 . Stable antiretroviral treatment include darunavir/ritonavir 600/100 every 12 hour least 4 week . 4 . HIV viral load &lt; 50 copies/mL least 12 week . 5 . Resistance test ( Genotype Virtual Phenotype ) start tipranavir treatment . 6 . Darunavir vIQ &gt; = 2 . 7 . Subject able follow treatment period . 8 . In woman , negative pregnancy test fertile age ( define least one year menopause undergoing surgical sterilisation technique ) , undertake use barrier contraceptive method study . 9 . Signature informed consent . 1 . AIDSdefining illness last 4 week . 2 . Suspicion unsuitable antiretroviral treatment compliance . 3 . In woman , pregnancy breastfeeding . 4 . Record suspicion incapability cooperate appropriate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Darunavir/ritonavir</keyword>
	<keyword>virtual inhibitory quotient</keyword>
	<keyword>dose reduction</keyword>
</DOC>